Jilin Aodong Pharmaceutical Group Co., Ltd. (SHE:000623)

China flag China · Delayed Price · Currency is CNY
18.51
-0.15 (-0.80%)
Mar 4, 2026, 3:04 PM CST
13.63%
Market Cap 21.88B
Revenue (ttm) 2.34B
Net Income (ttm) 2.57B
Shares Out 1.17B
EPS (ttm) 2.18
PE Ratio 8.56
Forward PE n/a
Dividend 0.50 (2.65%)
Ex-Dividend Date Oct 22, 2025
Volume 16,201,174
Average Volume 17,403,300
Open 18.83
Previous Close 18.66
Day's Range 18.42 - 18.83
52-Week Range 14.85 - 22.08
Beta 0.66
RSI 38.03
Earnings Date Apr 18, 2026

About SHE:000623

Jilin Aodong Pharmaceutical Group Co., Ltd. engages in the manufacture and sale of pharmaceutical products in China. The company provides various drugs, such as oral liquid solutions, injections, capsules, granules, pills, tablets, Chinese herbal medicines, powders, tonic medicines, syrups, and spirits, as well as enzymes, biochemical medicine, and plant chemical medicine. It is also involved in the highway construction and toll collection businesses; animal husbandry activities; manufacture of specialty chemicals; production and supply of heat... [Read more]

Sector Healthcare
Founded 1957
Employees 5,454
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000623
Full Company Profile

Financial Performance

In 2024, SHE:000623's revenue was 2.61 billion, a decrease of -24.31% compared to the previous year's 3.45 billion. Earnings were 1.55 billion, an increase of 6.27%.

Financial Statements

News

There is no news available yet.